Daily FNArena News

Brokers assess the recent Big Bank first half earnings reports and provide their views on how the second half may play out.

The government and Pathology Australia have struck a deal on collection centre rents and brokers look at the implications for pathology providers.

Buyers returned to the spot uranium market last week as term contract settlements moved forward.

Michael Gable of Fairmont Equities suggest recent star performer Eclipx may be set to offer a better entry point.

Brokers laud the acquisition strategy of Integral Diagnostics, as it expands its regional footprint in Victoria.

James Montier’s little treasure can make a better investor out of all of us.

Nick Linton-Ffrost of Fifth Wave suggests 5400-25 to the upside and 5200-50 to the downside are the key levels to watch for the index.

Aristocrat Leisure stunned brokers by delivering a resounding upgrade to the earnings outlook, as it grows outright sales, market share, margins and new segments.

This week’s Tweets on Twitter by Your Editor.

CSR delivered a credible FY16 result, brokers contend. Yet, while building demand extends for another 12-18 months, several believe the going is as good as it gets for CSR.